Epigenetics studies heritable regulation without changing DNA sequence: DNA methylation, histone PTMs, chromatin remodeling, and non-coding RNAs. We provide histone PTM antibodies, methylation/demethylation & acetylation readout tools, and chemical probes (HDAC, EZH2, BET, etc.) linking chromatin states to transcriptional control.
Focus areas: activating vs repressive marks & enhancer logic, DNA methylation & TET oxidation, PRC2 silencing domains, SWI/SNF-driven accessibility
Histone-modifying enzymes (e.g. EZH2) link to the histone-modifying hub; DNA methylation and remodeling modules below.
Commonly used for mechanistic studies; follow your lab SOP, compound datasheets, and ethics approvals.
| Compound | Targets / pathways | Experimental notes |
|---|---|---|
| Vorinostat (SAHA) | HDAC (pan; class-dependent at concentration) | Common for acetylome/expression readouts; cytotoxicity & isoform selectivity vary. |
| Trichostatin A (TSA) | HDAC (classic tool) | Potent in vitro; light-sensitive—storage and vehicle controls matter. |
| MS-275 (Entinostat) | HDAC1/3-biased (interpret cautiously) | Often used as a more “in vivo–tolerable” HDACi comparator—validate selectivity. |
| GSK126 | EZH2 methyltransferase activity | H3K27me3 inhibition readouts; separate catalytic vs scaffolding/compensation. |
| UNC0638 | G9a / GLP (H3K9 methyltransferases) | Heterochromatin/silencing; cross-talk with DNMT axis and off-targets. |
| JQ1 | BET bromodomains (BRD2/3/4, etc.) | Super-enhancer/transcriptional condensates; validate paralog selectivity. |
| Decitabine | DNMTs (DNA incorporation) | Hypomethylation with replication coupling; manage cytotoxicity per SOP/ethics. |